Skip to main content
. 2023 Jan 26;29(2):458–466. doi: 10.1038/s41591-022-02181-8

Extended Data Fig. 7. Characterization of organoids following BRAF targeted therapy.

Extended Data Fig. 7

a, Pearson correlation (two-sided) of ISGs induction (average of log2FC of ISGs in Fig. 4a) and MAPK pathway inhibition (average of log2FC of DUSP6, ETV4, ETV5, and SPRY4) in DT-treated organoids. b, Log2FC of gene expression (measured by qPCR) of indicated ISGs in organoids (derived from patient 18) treated with DP for 72 hours (n = 3 independent biological experiments, data are presented as mean values +/− SEM). c, Indicated organoids were treated with various doses of DT or DE for 72 hours, and subjected to cell viability assay (n = 3, data are presented as mean values +/− SEM). d, Relative DUSP6 expression in organoid treated with various doses of DT or DE for 6 hours (n = 3, data are presented as mean values +/− SEM). e, ISGs induction in indicated organoids treated with two different doses of DT (n = 3, data are presented as mean values +/− SEM).